10469748 · Active · incorporated 9 years, 8 months ago · Oxford
Biotech Biotech & Life Sciences Drug Discovery Series B+
A biopharmaceutical company focused on developing cancer immunotherapies by targeting Dark Antigens and T-cell biology.
See the complete cap table with every shareholder, founder tags, dilution across 73 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.